|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/5377 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 9/20 | (2006.01) |
| (11) | Number of the document | 3220916 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15860676.4 |
| Date of filing the European patent application | 2015-11-17 | |
| (97) | Date of publication of the European application | 2017-09-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-19 |
| (46) | Date of publication of the claims translation | 2023-07-25 |
| (86) | Number | PCT/US2015/061194 |
| Date | 2015-11-17 |
| (87) | Number | WO 2016/081523 |
| Date | 2016-05-26 |
| (30) | Number | Date | Country code |
| 201462080985 P | 2014-11-17 | US | |
| 201562166572 P | 2015-05-26 | US | |
| 201562251903 P | 2015-11-06 | US |
| (72) |
KEILHACK, Heike , US
TRUITT, Brett , US
SUZUKI, Yuta , JP
MURASE, Tsukasa , JP
SHIKATA, Futoshi , JP
|
| (73) |
Epizyme, Inc. ,
400 Technology Square, 4th Floor, Cambridge, MA 02139,
US
Eisai R&D Management Co., Ltd. , 6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088, JP |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Vėžio gydymo N-((4,6-dimetil-2-okso-1,2-dihidropiridin-3-il)metil)-5- (etil(tetrahidro-2H-piran-4-il)amino)-4-metil-4’-(morfolinometil)-[1,1’- bifenil]-3-karboksamidu būdas |
| METHOD FOR TREATING CANCER WITH N-((4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL(TETRAHYDRO-2H-PYRAN-4-YL) AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE |
| Payment date | Validity (years) | Amount | |
| 2024-10-21 | 10 | 231.00 EUR |
| 2025-11-17 |